Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com

Posted by on Jan 3rd, 2025

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research report released on Thursday morning. The brokerage issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Trading Up 2.9 %

NASDAQ:RKDA opened at $6.09 on Thursday. The firm has a fifty day simple moving average of $4.57 and a two-hundred day simple moving average of $3.51. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $10.31. The stock has a market capitalization of $8.31 million, a price-to-earnings ratio of -1.42 and a beta of 1.19.

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.

Read More

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.